Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Xinnate logo — Using the body's natural defense to promote healing

Xinnate

Using the body's natural defense to promote healing

Founded 2019 Sweden Sweden 8 employees Biopharma, Biotechnology +2

General Information

Company Name Xinnate
Founded Year 2019
Location Sweden Sweden +1
Employees 8
Industries Biopharma, Biotechnology, Health and Wellness +1
Social

Get notified when Xinnate moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Xinnate

Xinnate is a biopharmaceutical startup based in Lund, Sweden. The company's slogan, "Using the body's natural defense to promote healing," reflects its core mission of developing novel pharmaceutical therapies based on immune modulating peptides. Specifically, Xinnate focuses on addressing dysfunctional healing by controlling the presence of microbials and the complex interplay of inflammatory responses. One of Xinnate's flagship initiatives is the development of TCP25, a groundbreaking technology with potential applications in treating conditions such as Epidermolysis bullosa (EB). The company is currently conducting a phase 1b clinical study in patients with EB, demonstrating its commitment to advancing the therapeutic potential of its innovative approach. Founded in 2019, Xinnate operates at the intersection of biopharma, biotechnology, health, wellness, and life sciences, positioning itself as a key player in the evolving landscape of healthcare innovation. Looking ahead, Xinnate envisions late-stage clinical development and commercialization through strategic partnerships with leading pharmaceutical companies. As of now, specific details about Xinnate's headquarters, last investment, or investors are not available. These factors can play a significant role in understanding the company's current financial standing and growth trajectory. However, given the promising nature of Xinnate's focus and its potential to address critical medical needs, the company presents an intriguing opportunity for venture capital investment. With its innovative approach and ambitious clinical programs, Xinnate stands poised to make a meaningful impact in the pharmaceutical industry.

Taxonomy: pharmaceutical development, immune modulating peptides, clinical research, Epidermolysis bullosa, biological systems, inflammatory illnesses, infections, wound treatment, patented medications, hydrogel, biomaterials, biopharmaceutical, clinical program, surgical materials

No funding data available for Xinnate yet.

Get notified when Xinnate raises funding

Xinnate Alternatives & Competitors

Xinnate vs
Firma Clinical Research
Firma Clinical Research United States

We are a quality-certified, global CRO.

Private Equity
85 employees
Pharmaceutical
Xinnate vs
KABS Laboratories Inc.
KABS Laboratories Inc. Canada

One product: Commitment.

91 employees
Biotechnology, Health Care
Xinnate vs
Medzus®
Medzus® India

Believe to Achieve

1 employees
Health Care, Medical Devices

FAQ About Xinnate

Using the body's natural defense to promote healing
Xinnate was founded in 2019.
Xinnate is headquartered in Sweden.
Xinnate operates in the following industries: Biopharma, Biotechnology, Health and Wellness, Life Sciences.
Xinnate has approximately 8 employees.
Top alternatives and competitors to Xinnate include Firma Clinical Research, KABS Laboratories Inc., Medzus® , Bio Analytical Research Corporation South Africa (Pty) Ltd, Novozen Healthcare LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Xinnate and Firma Clinical Research are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Xinnate and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy